Latest stories from the Sanger Institute March 2024

Studying cancer and pre-cancer in Latin America

Dr Daniela Robles Espinoza, an International Fellow at the Sanger Institute, and Assistant Professor at National Autonomous University of Mexico, has recently been awarded a Wellcome Career Development Fellowship – funding designed to support the future leaders of international research. Her team studies the genetic causes and architecture of acral melanoma - an understudied disease that is the most common type of melanoma in Mexico. ?Read more…

Digital transformation and a new era in science

Digital technologies are rapidly evolving. The Wellcome Sanger Institute and its partners are mobilising to support these technological advancements, which will have a powerful impact on our understanding of health, disease, evolution, climate change and beyond. With the astonishing rise of generative AI, the Sanger Institute will actively create publically-available generative models of aspects of human cells, alongside other biological systems. James McCafferty , Chief Information Officer at the Wellcome Sanger Institute, discusses the latest opportunities and challenges for research. Read more...

Lives could be saved from tropical disease with new rapid test

Globally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before they are diagnosed. A new rapid test could save lives by diagnosing patients in hours, rather than several days taken by current bacterial culture methods, meaning they receive the correct antibiotics faster. The test uses CRISPR to detect a genetic target that is specific to Burkholderia pseudomallei, the bacterium that causes melioidosis. Read more...

Climate change impacts on microbiome explored in new study

A new study aims to investigate the role of rising sea levels and salinated drinking water on the gut microbiome and human health in coastal regions of Bangladesh already impacted by climate change. The findings will help the world understand what is needed most to counter the effects of climate change, especially in vulnerable communities such as these.?Read more...

The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynaecological cancers, biliary tract cancers and melanoma. In the future, understanding more about these bacteria strains can help drive the development of next-generation probiotics, known as ‘live biotherapeutic products’, that focus on modulating the microbiome to support combination immunotherapy from the inside. ?Read more...

Careers at Sanger Institute

Meet our people

Life at the Sanger Institute is truly unique where collaboration, innovation and support for people as individuals are demonstrated in everything we do. Set across 130 acres, just outside of Cambridge, our people are shaping the future by delivering life-changing science with the reach, scale, and creativity to solve some of humanity’s greatest challenges.

We have over 1,200 people at the Sanger Institute, from 70+ nationalities. Explore what our employees, students, and alumni from across our Institute have to say about what they do, life at Sanger Institute and more.

Current jobs

Sanger Excellence Fellowship: We're offering 4 positions for Early Career Researchers from Black heritage backgrounds

International Fellowship: Are you a scientist based in a Low or Middle Income country? Are interested in the research we do at Sanger? Apply now, the fellowship is accompanied with a stipend of ￡100,000

Head of Research and Product Development: Are you a senior leader passionate about public health, genomics, and product development? Have you led transformative projects for high-profile clients at the intersection of science, technology, and health??

See all our jobs

Copyright (C) 2024 Wellcome Sanger Institute. All rights reserved.

For more stories from the Wellcome Sanger Institute visit: